These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 3024746)

  • 1. Cerebrospinal fluid levels of angiotensin-converting enzyme, acetylcholinesterase, and dopamine metabolites in dementia associated with Alzheimer's disease and Parkinson's disease: a correlative study.
    Zubenko GS; Marquis JK; Volicer L; Direnfeld LK; Langlais PJ; Nixon RA
    Biol Psychiatry; 1986 Dec; 21(14):1365-81. PubMed ID: 3024746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal fluid levels of angiotensin-converting enzyme in Alzheimer's disease, Parkinson's disease and progressive supranuclear palsy.
    Zubenko GS; Volicer L; Direnfeld LK; Freeman M; Langlais PJ; Nixon RA
    Brain Res; 1985 Mar; 328(2):215-21. PubMed ID: 2985183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurochemical markers in the cerebrospinal fluid of patients with Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis and normal controls.
    Hartikainen P; Reinikainen KJ; Soininen H; Sirviö J; Soikkeli R; Riekkinen PJ
    J Neural Transm Park Dis Dement Sect; 1992; 4(1):53-68. PubMed ID: 1347220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatostatin-like immunoreactivity in the cerebrospinal fluid of patients with Parkinson's disease and its relation to dementia.
    Jolkkonen J; Soininen H; Halonen T; Ylinen A; Laulumaa V; Laakso M; Riekkinen P
    J Neurol Neurosurg Psychiatry; 1986 Dec; 49(12):1374-7. PubMed ID: 2433403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between changes in CSF dopamine turnover and development of dyskinesia in Parkinson's disease.
    Lunardi G; Galati S; Tropepi D; Moschella V; Brusa L; Pierantozzi M; Stefani A; Rossi S; Fornai F; Fedele E; Stanzione P; Hainsworth AH; Pisani A
    Parkinsonism Relat Disord; 2009 Jun; 15(5):383-9. PubMed ID: 19010710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parkinson's disease. The possible relationship of laterality to dementia and neurochemical findings.
    Direnfeld LK; Albert ML; Volicer L; Langlais PJ; Marquis J; Kaplan E
    Arch Neurol; 1984 Sep; 41(9):935-41. PubMed ID: 6477229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoamine metabolites in normal human cerebrospinal fluid and in degenerative diseases of the central nervous system.
    González-Quevedo A; García JC; Fernández R; Fernández Cartaya L
    Bol Estud Med Biol; 1993; 41(1-4):13-9. PubMed ID: 7521168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homovanillic acid in CSF of mild stage Parkinson's disease patients correlates with motor impairment.
    Stefani A; Pierantozzi M; Olivola E; Galati S; Cerroni R; D'Angelo V; Hainsworth AH; Saviozzi V; Fedele E; Liguori C
    Neurochem Int; 2017 May; 105():58-63. PubMed ID: 28108196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acetylcholinesterase activity in cerebrospinal fluid of patients with Alzheimer's disease and senile dementia.
    Nakano S; Kato T; Nakamura S; Kameyama M
    J Neurol Sci; 1986 Sep; 75(2):213-23. PubMed ID: 3760912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acetylcholinesterase and butyrylcholinesterase activities in cerebrospinal fluid from different levels of the neuraxis of patients with dementia of the Alzheimer type.
    Appleyard ME; McDonald B
    J Neurol Neurosurg Psychiatry; 1992 Nov; 55(11):1074-8. PubMed ID: 1469405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laboratory examinations correlated with severity of dementia.
    Oishi M; Mochizuki Y; Yoshihashi H; Takasu T; Nakano E
    Ann Clin Lab Sci; 1996; 26(4):340-5. PubMed ID: 8800434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gamma-aminobutyric acid and homovanillic acid concentration in the CSF of patients with senile dementia of Alzheimer's type.
    Zimmer R; Teelken AW; Trieling WB; Weber W; Weihmayr T; Lauter H
    Arch Neurol; 1984 Jun; 41(6):602-4. PubMed ID: 6721733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations in cerebrospinal fluid dopamine metabolites following physostigmine infusion.
    Davis KL; Faull KF; Hollister LE; Barchas JD; Berger PA
    Psychopharmacology (Berl); 1981; 72(2):155-60. PubMed ID: 6782605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal fluid acetylcholinesterase activity in senile dementia of the Alzheimer type.
    Tune L; Gucker S; Folstein M; Oshida L; Coyle JT
    Ann Neurol; 1985 Jan; 17(1):46-8. PubMed ID: 3985585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine (DA) and serotonin metabolic levels in the cerebrospinal fluid (CSF) in Alzheimer's presenile dementia under basic conditions and after stimulation with cerebral cortex phospholipids (BC-PL).
    Argentiero V; Tavolato B
    J Neurol; 1980; 224(1):53-8. PubMed ID: 6157799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circadian rhythm of CSF monoamines and hypocretin-1 in restless legs syndrome and Parkinson's disease.
    Poceta JS; Parsons L; Engelland S; Kripke DF
    Sleep Med; 2009 Jan; 10(1):129-33. PubMed ID: 18207455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acetyl- and butyrylcholinesterase activity in the cerebrospinal fluid of patients with Parkinson's disease.
    Sirviö J; Soininen HS; Kutvonen R; Hyttinen JM; Helkala EL; Riekkinen PJ
    J Neurol Sci; 1987 Nov; 81(2-3):273-9. PubMed ID: 3694232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central amine metabolism in Alzheimer's disease: in vivo relationship to cognitive deficit.
    Mann JJ; Stanley M; Neophytides A; de Leon MJ; Ferris SH; Gershon S
    Neurobiol Aging; 1981; 2(1):57-60. PubMed ID: 7266742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of cerebrospinal fluid levels of dopamine metabolites by gas chromatography.
    Watson E; Wilk S
    Psychopharmacologia; 1975 Apr; 42(1):57-6. PubMed ID: 1153623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Acetylcholinesterase activity in CSF in senile dementia of Alzheimer type, vascular dementia, and Parkinson's disease].
    Yoshinaga J; Sasaki T; Ideshita H; Hikiji A; Kuwaki T
    Rinsho Shinkeigaku; 1989 Mar; 29(3):376-8. PubMed ID: 2752667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.